Recombinant CD45 (Apamistamab Biosimilar) antibody

Catalog No. ABIN7597512

This Mouse Monoclonal antibody specifically detects CD45 (Apamistamab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant CD45 (Apamistamab Biosimilar) antibody (ABIN7597512)

Target: CD45 (Apamistamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CD45 (Apamistamab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD45 (Apamistamab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Apamistamab Biosimilar Antibody

Specificity: T200, Leukocyte common antigen, CD45, L-CA, Receptor-type tyrosine-protein phosphatase C, PTPRC

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD45 (Apamistamab Biosimilar)

Target: CD45 (Apamistamab Biosimilar)

Alternative Name: Apamistamab Biosimilar

Target Type: Biosimilar

Background: T200, Leukocyte common antigen, CD45, L-CA, Receptor-type tyrosine-protein phosphatase C, PTPRC

UniProt: P08575